Note: This section contains information in English only.
Tue, 09 Sep 2025 12:30:04 GMT
Source: Dukascopy Bank SA
Novartis will buy Tourmaline Bio for $48/share ($1.4B). Tourmaline develops pacibekitug, a therapy targeting inflammation in atherosclerotic cardiovascular disease.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.